SEI Investments’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75.9K | Sell |
67,721
-122
| -0.2% | -$137 | ﹤0.01% | 2717 |
|
|
2025
Q1 | $53.6K | Buy |
+67,843
| New | +$53.6K | ﹤0.01% | 2672 |
|
|
2024
Q1 | – | Sell |
-18,066
| Closed | -$67.6K | – | 2651 |
|
|
2023
Q4 | $67.6K | Buy |
+18,066
| New | +$67.6K | ﹤0.01% | 2542 |
|
|
2022
Q4 | – | Sell |
-65,144
| Closed | -$1.46M | – | 2580 |
|
|
2022
Q3 | $1.46M | Buy |
65,144
+12,241
| +23% | +$274K | ﹤0.01% | 1669 |
|
|
2022
Q2 | $1.31M | Buy |
+52,903
| New | +$1.31M | ﹤0.01% | 1726 |
|
|
2021
Q4 | – | Sell |
-5,922
| Closed | -$353K | – | 2607 |
|
|
2021
Q3 | $353K | Sell |
5,922
-860
| -13% | -$51.3K | ﹤0.01% | 2243 |
|
|
2021
Q2 | $588K | Sell |
6,782
-12,251
| -64% | -$1.06M | ﹤0.01% | 2009 |
|
|
2021
Q1 | $1.66M | Buy |
19,033
+630
| +3% | +$54.9K | ﹤0.01% | 1536 |
|
|
2020
Q4 | $1.67M | Sell |
18,403
-2,242
| -11% | -$204K | ﹤0.01% | 1470 |
|
|
2020
Q3 | $823K | Buy |
20,645
+4,522
| +28% | +$180K | ﹤0.01% | 1677 |
|
|
2020
Q2 | $553K | Sell |
16,123
-8,083
| -33% | -$277K | ﹤0.01% | 1801 |
|
|
2020
Q1 | $538K | Buy |
+24,206
| New | +$538K | ﹤0.01% | 1714 |
|
|
2019
Q1 | – | Sell |
-4,360
| Closed | -$71K | – | 2925 |
|
|
2018
Q4 | $71K | Hold |
4,360
| – | – | ﹤0.01% | 2265 |
|
|
2018
Q3 | $71K | Hold |
4,360
| – | – | ﹤0.01% | 2152 |
|
|
2018
Q2 | $49K | Buy |
+4,360
| New | +$49K | ﹤0.01% | 2513 |
|